About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

NeoCart Phase 2 Clinical Trial

NCT00548119·6 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Histogenics Corporation

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients presenting with symptomatic knee pain indicative of an articular cartilage injury and able and willing to give informed consent.

You may not be if

Patients with any previous surgical treatment other than debridement or microfracture of the study cartilage defect.

The record

StatusCompleted

PhasePhase 2

Taking part30

StartedDec 2006

UpdatedApr 21, 2014

Conditions

Articular Cartilage Damage

Where6

UCSF
San Francisco, California, United States
TRIA Orthopedic Center
Bloomington, Minnesota, United States
Hospital for Special Surgery
New York, New York, United States

Clareo Health | NeoCart Phase 2 Clinical Trial